A carregar...
SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
Background Although surgical resection is the first line therapy for acromegaly, many patients do not achieve biochemical remission after surgery and require the adjuvant therapy including medical treatment (somatostatin analogues; SSA, GH antagonist, and dopamine agonist), conventional radiotherapy...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552098/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-436 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|